BACKGROUND: The traditional definition of delayed graft function (DGF) rests on dialysis requirement during the first postoperative week. Subsequently, a more objective and "functional" definition of DGF (fDGF) has been proposed as an alternative to this dialysis-based definition of DGF (dDGF) and defined as a failure of the serum creatinine to decrease by at least 10% daily on 3 successive days during the first week posttransplantation, irrespective of dialysis requirement. However, an association between fDGF and long-term graft failure has not been fully established, and it is unknown whether fDGF is a better marker of subsequent outcomes than dDGF. METHODS: We studied 750 adult deceased donor kidney transplant recipients (1996-2006) and analyzed the association between these two DGF definitions and long-term graft outcome. RESULTS: Univariable associations with death-censored graft failure were seen for both dDGF and fDGF (hazard ratio [HR] 1.59; 95% confidence interval [CI] 1.16-2.18; P=0.004 and HR 1.72; 95% CI 1.26-2.36; P=0.001, respectively). On bivariable analysis (dDGF vs. fDGF), dDGF lost significance, whereas the effect of fDGF persisted (HR 1.52; 95%CI 1.03-2.25; P=0.04). This was also the case in a multivariable model, where fDGF but not dDGF was significantly associated with graft failure (HR 1.47; 95%CI 1.06-2.03; P=0.02). Results were similar for overall graft failure. CONCLUSIONS: This study confirms the utility of fDGF as an early marker of subsequent inferior allograft outcomes, suggesting superiority over the traditional (often subjective) dialysis-based definition. Wider adoption of the fDGF definition should be considered, both as a risk-stratification tool in clinical practice and a clinical trial endpoint.
BACKGROUND: The traditional definition of delayed graft function (DGF) rests on dialysis requirement during the first postoperative week. Subsequently, a more objective and "functional" definition of DGF (fDGF) has been proposed as an alternative to this dialysis-based definition of DGF (dDGF) and defined as a failure of the serum creatinine to decrease by at least 10% daily on 3 successive days during the first week posttransplantation, irrespective of dialysis requirement. However, an association between fDGF and long-term graft failure has not been fully established, and it is unknown whether fDGF is a better marker of subsequent outcomes than dDGF. METHODS: We studied 750 adult deceased donor kidney transplant recipients (1996-2006) and analyzed the association between these two DGF definitions and long-term graft outcome. RESULTS: Univariable associations with death-censored graft failure were seen for both dDGF and fDGF (hazard ratio [HR] 1.59; 95% confidence interval [CI] 1.16-2.18; P=0.004 and HR 1.72; 95% CI 1.26-2.36; P=0.001, respectively). On bivariable analysis (dDGF vs. fDGF), dDGF lost significance, whereas the effect of fDGF persisted (HR 1.52; 95%CI 1.03-2.25; P=0.04). This was also the case in a multivariable model, where fDGF but not dDGF was significantly associated with graft failure (HR 1.47; 95%CI 1.06-2.03; P=0.02). Results were similar for overall graft failure. CONCLUSIONS: This study confirms the utility of fDGF as an early marker of subsequent inferior allograft outcomes, suggesting superiority over the traditional (often subjective) dialysis-based definition. Wider adoption of the fDGF definition should be considered, both as a risk-stratification tool in clinical practice and a clinical trial endpoint.
Authors: Valeria R Mas; Mariano J Scian; Kellie J Archer; Jihee L Suh; Krystle G David; Qing Ren; Todd W B Gehr; Anne L King; Marc P Posner; Thomas F Mueller; Daniel G Maluf Journal: Mol Med Date: 2011-09-06 Impact factor: 6.354
Authors: Anna Zuk; Paul M Palevsky; Linda Fried; Frank E Harrell; Samina Khan; Dianne B McKay; Luke Devey; Lakhmir Chawla; Mark de Caestecker; James S Kaufman; B Taylor Thompson; Anupam Agarwal; Tom Greene; Mark Douglas Okusa; Joseph V Bonventre; Laura M Dember; Kathleen D Liu; Benjamin D Humphreys; Daniel Gossett; Yining Xie; Jenna M Norton; Paul L Kimmel; Robert A Star Journal: Clin J Am Soc Nephrol Date: 2018-03-09 Impact factor: 8.237
Authors: Alessandro Domenici; Maria Cristina Comunian; Loredana Fazzari; Francesca Sivo; Angela Dinnella; Barbara Della Grotta; Giorgio Punzo; Paolo Menè Journal: Int J Nephrol Date: 2011-09-15
Authors: Sana Waheed; Ahmad Sakr; Neha D Chheda; Gregory M Lucas; Michelle Estrella; Derek M Fine; Mohamed G Atta Journal: PLoS One Date: 2015-06-10 Impact factor: 3.240
Authors: Arthur J Matas; Erika Helgeson; Ann Fieberg; Robert Leduc; Robert S Gaston; Bertram L Kasiske; David Rush; Lawrence Hunsicker; Fernando Cosio; Joseph P Grande; J Michael Cecka; John Connett; Roslyn B Mannon Journal: Transplantation Date: 2022-02-01 Impact factor: 5.385
Authors: Connie J Wang; Ahmad Tuffaha; Milind A Phadnis; Jonathan D Mahnken; James B Wetmore Journal: Ann Transplant Date: 2018-04-03 Impact factor: 1.530
Authors: Gertrude J Nieuwenhuijs-Moeke; Tobias M Huijink; Robert A Pol; Mostafa El Moumni; Johannes Gm Burgerhof; Michel Mrf Struys; Stefan P Berger Journal: J Clin Med Date: 2019-10-02 Impact factor: 4.241